Form 8K Aspire Biopharma Holdings Inc For: 19 August
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aspire Biopharma Holdings Inc (ASBP)
The Aspire Biopharma Holdings share price today is 8.5100, view NASDAQ ASBP stock exchange data. Track the latest Aspire Biopharma Holdings share price with real-time updates on ASBP stock performance including market cap, day range, 52-week range and dividend yield. Access ASBP charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.0700
8.7000
52 wk Range
3.3090
704.5200
ASBP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.07008.7000
52 wk Range
3.3090704.5200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ASBP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Form 8K Aspire Biopharma Holdings Inc For: 10 August- Investing.com
Form 8K Aspire Biopharma Holdings Inc For: 22 June- Investing.com
- Form 8K Aspire Biopharma Holdings Inc For: 19 August
- Investing.com
- Form 8K Aspire Biopharma Holdings Inc For: 10 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
13-08-2026
EPS / Forecast
-1.22 / --
Revenue / Forecast
63.1K / --
Compare ASBP to Peers and Sector
Metrics to compare | ASBP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASBPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −1.4x | −0.4x | |
PEG Ratio | −0.01 | −0.01 | 0.00 | |
Price/Book | 1.0x | 2.3x | 2.6x | |
Price / LTM Sales | 122.2x | 3.0x | 3.1x | |
Upside (Analyst Target) | - | 122.1% | 47.7% | |
Fair Value Upside | Unlock | 7.1% | 6.5% | Unlock |
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Aspire Biopharma Holdings (ASBP) Share Price Today?
The Aspire Biopharma Holdings share price today is 8.5100.
What is the current Aspire Biopharma Holdings (ASBP) share price and day range?
As of 31-08-2026, the Aspire Biopharma Holdings share price is 8.5100, with a previous close of 8.5100. The share price has ranged from 8.0700 to 8.7000 today, while the 52-week range spans from 3.3090 to 704.5200.
What Is the Aspire Biopharma Holdings Market Cap?
As of today, Aspire Biopharma Holdings market cap is 11.9400M.
What Is Aspire Biopharma Holdings's Earnings Per Share (TTM)?
The Aspire Biopharma Holdings EPS (TTM) is -33.3327.
From a Technical Analysis Perspective, Is ASBP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Aspire Biopharma Holdings Trade On?
Aspire Biopharma Holdings is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Aspire Biopharma Holdings?
The stock symbol for Aspire Biopharma Holdings is "ASBP."
How Many Times Has Aspire Biopharma Holdings Stock Split?
Aspire Biopharma Holdings has split 2 times.
What Is the ASBP After Hours Price?
ASBP's last after hours stock price is 8.4900, the stock has changed by -0.0200, or -0.2400%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.